Therapeutic Asset Ratings
1,482 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Idarubicine
Acute Leukemia
Kura Oncology, Inc.
P2/3
B
(62)
Inetetamab
HER2 Positive Breast Carcinoma
Fudan University
P2/3
B
(62)
Inno-206
Fallopian Tube Endometrioid Adenocarcinoma
National Cancer Institute (NCI)
P2/3
B
(62)
Inno-206
Recurrent Primary Peritoneal Endometrioid Adenocarcinoma
National Cancer Institute (NCI)
P2/3
B
(62)
Inno-206
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology Group
P2/3
B
(62)
Irinotecan
Recurrent Primary Peritoneal Endometrioid Adenocarcinoma
Roswell Park Cancer Institute
P2/3
B
(62)
Isavuconazole
Acute Myeloid Leukemia
M.D. Anderson Cancer Center
P2/3
B
(62)
Ketorolac Tromethamine
B-All
Merck Sharp & Dohme LLC
P2/3
B
(62)
LENVATINIB
Small Cell Lung Carcinoma
Peking Union Medical College Hospital
P2/3
B
(62)
Letrozole
Breast Disorder
Fujian Cancer Hospital
P2/3
B
(62)
Marijuana
Spinal Cord Injury
Khon Kaen University
P2/3
B
(62)
N-(5-ISOQUINOLINESULFONYL)-1,4-PERHYDRODIAZEPINE
Prostate Cancer
baotai Liang
P2/3
B
(62)
Nivolumab
Acute Myeloid Leukemia
Ludwig-Maximilians - University of Munich
P2/3
B
(62)
Nivolumab
Adenosquamous Lung Carcinoma
National Cancer Institute (NCI)
P2/3
B
(62)
Nivolumab
Infiltrating Bladder Urothelial Carcinoma
National Cancer Institute (NCI)
P2/3
B
(62)
Nivolumab
Muscle Invasive Ureter Urothelial Carcinoma
National Cancer Institute (NCI)
P2/3
B
(62)
Np-G2-044
Ovarian Cancer
Novita Pharmaceuticals, Inc.
P2/3
B
(62)
Opakalim
Focal Epilepsy
Biohaven Therapeutics Ltd.
P2/3
B
(62)
PEGASPARGASE
Acute Leukemia
Janssen Research & Development, LLC
P2/3
B
(62)
Pegylated Interferon Alpha2A
Melanoma
Diakonos Oncology Corporation
P2/3
B
(62)
Pembrolizumab
Infiltrating Bladder Urothelial Carcinoma
Fred Hutchinson Cancer Center
P2/3
B
(62)
Perflutren Lipid Microsphere Intravenous Suspension
Breast Cancer
UNC Lineberger Comprehensive Cancer Center
P2/3
B
(62)
Perflutren Lipid Microsphere Intravenous Suspension
Breast Carcinoma
Kibo Nam
P2/3
B
(62)
PIFLUFOLASTAT
Prostate Neoplasm
Novartis Pharmaceuticals
P2/3
B
(62)
PROPRANOLOL
Melanoma
Sarah Weiss
P2/3
B
(62)
Showing 351 to 375 of 1,482 assets
Previous
Page 15 of 60
Next